Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Institutions: Soonchunhyang University, Gachon University Gil Medical Center, Konkuk University Medical Center, Gyeongsang National University, Keimyung University Dongsan Medical Center, Keimyung University, Korea University, Korea University Medical Center, Dong-A University, Pusan National University Hospital, Samsung Medical Center, Sungkyunkwan University, Soonchunhyang University Hospital Bucheon, Wonju Severance Christian Hospital, Wonkwang University Hospital, Wonkwang University, Chonnam National University Hwasun Hospital, Jeonbuk National University Hospital, Jeonbuk National University, Ewha Womans University, Ewha Womans University Seoul Hospital
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2732035955